INVEX Therapeutics Ltd (IXC) — Cash Flow Quality Index

Latest as of June 2024: -0.27x

INVEX Therapeutics Ltd (IXC) has a Cash Flow Quality Index of -0.27x as of June 2024. Operating cash flow of AU$-126.75K is below net income of AU$470.89K, suggesting accrual-heavy earnings not yet converted to cash. Also explore INVEX Therapeutics Ltd asset portfolio for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.27x

Operating CF / Net Income

Operating Cash Flow

AU$-126.75K

AUD

Net Income

AU$470.89K

AUD

Data as of

Jun 2024

Most recent filing

Annual Cash Flow Quality Index for INVEX Therapeutics Ltd (None–None)

Year-by-year earnings quality comparison for INVEX Therapeutics Ltd. For live market cap and the full company financial profile, see market cap of INVEX Therapeutics Ltd.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.